학술논문
Moxetumomab Pasudotox: Clinical experience in relapsed/refractory hairy cell leukemia.
Document Type
Article
Author
Feurtado, Julie (NURSE); Kreitman, Robert J.
Source
Subject
*THERAPEUTIC use of monoclonal antibodies
*ANTHROPOMETRY
*ATTITUDE (Psychology)
*BLOOD cell count
*HYDRATION
*ORAL leukoplakia
*MEDICAL protocols
*MONOCLONAL antibodies
*NURSES
*PATIENT education
*THERAPEUTICS
*URINALYSIS
*OCCUPATIONAL roles
*TREATMENT effectiveness
*PATIENTS' attitudes
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1092-1095
Abstract
BACKGROUND: Moxetumomab pasudotox is a promising new therapy for the treatment of patients with relapsed/refractory hairy cell leukemia (R/R HCL), but practical guidance relating to its administration is limited. OBJECTIVES: This article describes clinical guidelines for the administration of moxetumomab pasudotox to patients with R/R HCL and presents related case studies. METHODS: A limited review of the literature on HCL was undertaken. FINDINGS: Nursing care of patients prescribed moxetumomab pasudotox includes monitoring clinical and laboratory parameters, managing side effects, being aware of signs of serious side effects, and maintaining patient hydration during administration. [ABSTRACT FROM AUTHOR]